Philip Niles, MD
NPI 1609136126 · Retina Specialist (Ophthalmology) Physician · Williamsville, NY
Enrolled with Medicare as Practitioner - Ophthalmology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1609136126
- Entity type
- Individual
- Primary specialty
- Retina Specialist (Ophthalmology) PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- 2861401 (NY)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
14 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
6,247 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Imaging of Retina92134 | 1,661 | $39 |
| Injection of Drug Into Eye67028 | 1,533 | $125 |
| Established Patient Complete Exam of Visual System92014 | 1,139 | $123 |
| Established Patient Problem Focused Exam of Visual System92012 | 1,054 | $87 |
| Photography of the Retina92250 | 582 | $36 |
| New Patient Complete Exam of Visual System92004 | 115 | $146 |
| Exam of Retinal Blood Vessels Using a Special Camera After Injection of a Dye |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Prednisolone Acetate | 361 | 164 |
| Moxifloxacin Hclbrand: Moxifloxacin | 139 | 109 |
| Ketorolac Tromethamine | 111 | 40 |
| Atropine Sulfate | 39 | 24 |
| Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol | 32 | 15 |
| Brimonidine Tartrate | 24 | 13 |
| Timolol Maleate | 22 | — |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$6,707 across 14 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2012-05-17
- Last updated
- 2020-04-17
- Certified
- 2020-04-17
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.